Pembrolizumab’s Lasting Impact and ctDNA Utility
In the ever-evolving landscape of cancer immunotherapy, a groundbreaking study has emerged that significantly advances our understanding of the long-term ...
Tag: immune checkpoint inhibitors in oncology
Nivolumab and Low-Dose Ipilimumab Fight Hypermutated Breast Cancer
In a groundbreaking advancement that may herald a new era for the treatment of metastatic breast cancer, researchers have unveiled ...
Pre- and Post-Surgery Immunotherapy Enhances Outcomes in Head and Neck Cancer
In a groundbreaking advancement for head and neck cancer treatment, a new phase 3 clinical trial led by Dana-Farber Brigham ...
High-Dose S-1 Combo Shows Safety in Gastric Cancer
In a groundbreaking phase I/II clinical trial, researchers have embarked on a pioneering investigation into the safety and efficacy of ...
Research Reveals Potential for Immunotherapy in Glioblastoma by Targeting Key Protein Suppression
New research from the Sylvester Comprehensive Cancer Center at the University of Miami presents a groundbreaking approach to treating glioblastoma, ...
Revolutionizing Thymic Carcinoma Therapy: A Dual-Strategy Breakthrough
In a groundbreaking study recently released in the esteemed journal The Lancet Oncology, researchers have unveiled a promising new approach ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!